PETACH TIKVA, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that ...

PETACH TIKVA, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will ...

Nanox Imaging Ltd. announced promising results from a clinical study showcasing its Nanox.ARC digital tomosynthesis system, which enhances musculoskeletal imaging and outperforms conventional ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography. In addition ...

Nano-X Imaging (NASDAQ:NNOX) received CE mark certification to market the Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud-based infrastructure.The company said new clinical ...

is a biotech company known for its innovative medical imaging systems. Its main product is Nanox.ARC, which is designed to make CT scanning much more affordable and accessible than products using ...

Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository ...

NANO-X IMAGING (NNOX) has received CE mark certification to market the multi-source Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud-based infrastructure. Nanox.ARC is a ...

NANO-X IMAGING (NNOX) will present data supporting the Nanox.ARC performance at the 2025 European Congress of Radiology, taking place February 26 – March 2 in Vienna, Austria. The Nanox.ARC is a ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography. In addition, can ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S.New clinical data supporting use of Nanox.ARC ...